SG11201607693WA - 6-substituted estradiol derivatives for the treatment of alzheimer's disease - Google Patents
6-substituted estradiol derivatives for the treatment of alzheimer's diseaseInfo
- Publication number
- SG11201607693WA SG11201607693WA SG11201607693WA SG11201607693WA SG11201607693WA SG 11201607693W A SG11201607693W A SG 11201607693WA SG 11201607693W A SG11201607693W A SG 11201607693WA SG 11201607693W A SG11201607693W A SG 11201607693WA SG 11201607693W A SG11201607693W A SG 11201607693WA
- Authority
- SG
- Singapore
- Prior art keywords
- alzheimer
- disease
- treatment
- estradiol derivatives
- substituted estradiol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461955578P | 2014-03-19 | 2014-03-19 | |
| PCT/US2015/021538 WO2015143201A2 (en) | 2014-03-19 | 2015-03-19 | 6-substituted estradiol derivatives for the treatment of alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201607693WA true SG11201607693WA (en) | 2016-10-28 |
Family
ID=54141046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201607693WA SG11201607693WA (en) | 2014-03-19 | 2015-03-19 | 6-substituted estradiol derivatives for the treatment of alzheimer's disease |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150265630A1 (en) |
| EP (1) | EP3119402A4 (en) |
| JP (1) | JP2017512769A (en) |
| KR (1) | KR20160136363A (en) |
| CN (1) | CN106255501A (en) |
| AU (2) | AU2015231172A1 (en) |
| BR (1) | BR112016021408A2 (en) |
| CA (1) | CA2940536A1 (en) |
| MX (1) | MX2016012045A (en) |
| SG (1) | SG11201607693WA (en) |
| WO (1) | WO2015143201A2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10174070B2 (en) * | 2005-09-30 | 2019-01-08 | Endece Llc | 6-substituted estradiol derivatives and methods of use |
| WO2008100560A2 (en) * | 2007-02-14 | 2008-08-21 | University Of Southern California | Estrogen receptor modulators, associated pharmaceutical compositions and methods of use |
| US9364486B2 (en) * | 2011-03-21 | 2016-06-14 | Endece Llc | 6-substituted estradiol derivatives for use in remyelination of nerve axons |
-
2015
- 2015-03-19 WO PCT/US2015/021538 patent/WO2015143201A2/en active Application Filing
- 2015-03-19 JP JP2016556841A patent/JP2017512769A/en active Pending
- 2015-03-19 MX MX2016012045A patent/MX2016012045A/en unknown
- 2015-03-19 CA CA2940536A patent/CA2940536A1/en not_active Abandoned
- 2015-03-19 SG SG11201607693WA patent/SG11201607693WA/en unknown
- 2015-03-19 AU AU2015231172A patent/AU2015231172A1/en not_active Abandoned
- 2015-03-19 US US14/663,043 patent/US20150265630A1/en not_active Abandoned
- 2015-03-19 BR BR112016021408A patent/BR112016021408A2/en not_active IP Right Cessation
- 2015-03-19 CN CN201580014623.7A patent/CN106255501A/en active Pending
- 2015-03-19 EP EP15765290.0A patent/EP3119402A4/en not_active Withdrawn
- 2015-03-19 KR KR1020167028986A patent/KR20160136363A/en unknown
-
2018
- 2018-02-12 AU AU2018201003A patent/AU2018201003A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2940536A1 (en) | 2015-09-24 |
| AU2018201003A1 (en) | 2018-03-01 |
| JP2017512769A (en) | 2017-05-25 |
| US20150265630A1 (en) | 2015-09-24 |
| AU2015231172A1 (en) | 2016-09-08 |
| EP3119402A4 (en) | 2017-11-01 |
| MX2016012045A (en) | 2017-01-19 |
| EP3119402A2 (en) | 2017-01-25 |
| CN106255501A (en) | 2016-12-21 |
| WO2015143201A2 (en) | 2015-09-24 |
| KR20160136363A (en) | 2016-11-29 |
| BR112016021408A2 (en) | 2017-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280530A (en) | Aadc polynucleotides for the treatment of parkinson's disease | |
| IL285722A (en) | Methods for treating alzheimer's disease | |
| ZA201605341B (en) | Methods of treating alzheimer's disease | |
| IL247085A0 (en) | Methods of treating alzheimer's disease | |
| EP3268086A4 (en) | Lsd for the treatment of alzheimer's disease | |
| IL263188B (en) | Treatment for parkinson's disease | |
| IL249502A0 (en) | Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies | |
| HK1243709A1 (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease | |
| DK3148588T3 (en) | N,n-bis-2-mercaptoethyl isophthalamide for the treatment of parkinson's disease | |
| SG11201607693WA (en) | 6-substituted estradiol derivatives for the treatment of alzheimer's disease | |
| ZA201807944B (en) | Treatment for parkinson's disease | |
| HK1245081A1 (en) | Methods for treating alzheimer's disease | |
| GB201511453D0 (en) | Treatment of alzheimer's disease | |
| GB201414038D0 (en) | Alzheimer's disease |